Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1983 1
1986 1
1988 1
1989 6
1990 4
1991 3
1992 5
1993 6
1994 13
1995 2
1996 1
1997 1
1998 2
1999 1
2000 3
2001 8
2002 1
2003 2
2004 1
2005 1
2006 3
2007 2
2008 3
2009 1
2011 1
2013 1
2014 1
2015 3
2016 3
2017 3
2018 3
2019 1
2021 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

86 results

Results by year

Filters applied: . Clear all
Page 1
Comprehensive analysis of the ErbB receptor family in pediatric nervous system tumors and rhabdomyosarcoma.
Varlet P, Bouffet E, Casanova M, Giangaspero F, Antonelli M, Hargrave D, Ladenstein R, Pearson A, Hawkins C, König FB, Rüschoff J, Schmauch C, Bühnemann C, Garin-Chesa P, Schweifer N, Uttenreuther-Fischer M, Gibson N, Ittrich C, Krämer N, Solca F, Stolze B, Geoerger B. Varlet P, et al. Among authors: garin chesa p. Pediatr Blood Cancer. 2022 Jan;69(1):e29316. doi: 10.1002/pbc.29316. Epub 2021 Sep 21. Pediatr Blood Cancer. 2022. PMID: 34546642
p53 mutations in chondrosarcoma.
Terek RM, Healey JH, Garin-Chesa P, Mak S, Huvos A, Albino AP. Terek RM, et al. Among authors: garin chesa p. Diagn Mol Pathol. 1998 Feb;7(1):51-6. doi: 10.1097/00019606-199802000-00009. Diagn Mol Pathol. 1998. PMID: 9646035
Molecular dissection of colorectal cancer in pre-clinical models identifies biomarkers predicting sensitivity to EGFR inhibitors.
Schütte M, Risch T, Abdavi-Azar N, Boehnke K, Schumacher D, Keil M, Yildiriman R, Jandrasits C, Borodina T, Amstislavskiy V, Worth CL, Schweiger C, Liebs S, Lange M, Warnatz HJ, Butcher LM, Barrett JE, Sultan M, Wierling C, Golob-Schwarzl N, Lax S, Uranitsch S, Becker M, Welte Y, Regan JL, Silvestrov M, Kehler I, Fusi A, Kessler T, Herwig R, Landegren U, Wienke D, Nilsson M, Velasco JA, Garin-Chesa P, Reinhard C, Beck S, Schäfer R, Regenbrecht CR, Henderson D, Lange B, Haybaeck J, Keilholz U, Hoffmann J, Lehrach H, Yaspo ML. Schütte M, et al. Among authors: garin chesa p. Nat Commun. 2017 Feb 10;8:14262. doi: 10.1038/ncomms14262. Nat Commun. 2017. PMID: 28186126 Free PMC article.
Targeted disruption of mouse fibroblast activation protein.
Niedermeyer J, Kriz M, Hilberg F, Garin-Chesa P, Bamberger U, Lenter MC, Park J, Viertel B, Püschner H, Mauz M, Rettig WJ, Schnapp A. Niedermeyer J, et al. Among authors: garin chesa p. Mol Cell Biol. 2000 Feb;20(3):1089-94. doi: 10.1128/MCB.20.3.1089-1094.2000. Mol Cell Biol. 2000. PMID: 10629066 Free PMC article.
Phase I dose-escalation trial investigating volasertib as monotherapy or in combination with cytarabine in patients with relapsed/refractory acute myeloid leukaemia.
Ottmann OG, Müller-Tidow C, Krämer A, Schlenk RF, Lübbert M, Bug G, Krug U, Bochtler T, Voss F, Taube T, Liu D, Garin-Chesa P, Döhner H. Ottmann OG, et al. Among authors: garin chesa p. Br J Haematol. 2019 Mar;184(6):1018-1021. doi: 10.1111/bjh.15204. Epub 2018 Jun 8. Br J Haematol. 2019. PMID: 29882583 Free article. Clinical Trial. No abstract available.
hGPR87 contributes to viability of human tumor cells.
Glatt S, Halbauer D, Heindl S, Wernitznig A, Kozina D, Su KC, Puri C, Garin-Chesa P, Sommergruber W. Glatt S, et al. Among authors: garin chesa p. Int J Cancer. 2008 May 1;122(9):2008-16. doi: 10.1002/ijc.23349. Int J Cancer. 2008. PMID: 18183596 Free article.
Triple Angiokinase Inhibitor Nintedanib Directly Inhibits Tumor Cell Growth and Induces Tumor Shrinkage via Blocking Oncogenic Receptor Tyrosine Kinases.
Hilberg F, Tontsch-Grunt U, Baum A, Le AT, Doebele RC, Lieb S, Gianni D, Voss T, Garin-Chesa P, Haslinger C, Kraut N. Hilberg F, et al. Among authors: garin chesa p. J Pharmacol Exp Ther. 2018 Mar;364(3):494-503. doi: 10.1124/jpet.117.244129. Epub 2017 Dec 20. J Pharmacol Exp Ther. 2018. PMID: 29263244 Free PMC article.
A highly selective telomerase inhibitor limiting human cancer cell proliferation.
Damm K, Hemmann U, Garin-Chesa P, Hauel N, Kauffmann I, Priepke H, Niestroj C, Daiber C, Enenkel B, Guilliard B, Lauritsch I, Müller E, Pascolo E, Sauter G, Pantic M, Martens UM, Wenz C, Lingner J, Kraut N, Rettig WJ, Schnapp A. Damm K, et al. Among authors: garin chesa p. EMBO J. 2001 Dec 17;20(24):6958-68. doi: 10.1093/emboj/20.24.6958. EMBO J. 2001. PMID: 11742973 Free PMC article.
86 results